Melanoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) No edit summary |
YazanDaaboul (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
The National Comprehensive Cancer Network (NCCN) recommends the following:<ref name="pmid23584343">{{cite journal| author=Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A et al.| title=Melanoma, version 2.2013: featured updates to the NCCN guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 4 | pages= 395-407 | pmid=23584343 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23584343 }} </ref> | |||
===Stage 0 at Diagnosis=== | ===Stage 0 at Diagnosis=== | ||
| Line 31: | Line 31: | ||
* Patient education regarding self-lymph node exam | * Patient education regarding self-lymph node exam | ||
* Avoidance of ultraviolet radiation exposure | * Avoidance of ultraviolet radiation exposure | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 23:50, 21 August 2015
|
Melanoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Melanoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Melanoma secondary prevention |
|
Risk calculators and risk factors for Melanoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.
Overview
The choice of work-up for secondary prevention of melanoma is based on the stage of melanoma at diagnosis. Secondary prevention includes avoidance of ultraviolet radiation exposure, routine dermatologic evaluations, and chest and brain imaging.
Secondary Prevention
The National Comprehensive Cancer Network (NCCN) recommends the following:[1]
Stage 0 at Diagnosis
- Annual dermatologic evaluation for life
- Patient education regarding monthly self-skin exams
- Avoidance of ultraviolet radiation exposure
Stage IA at Diagnosis
- Dermatologic evaluation every 3-12 months for the first 5 years following diagnosis then annually thereafter
- Patient education regarding monthly self-skin exams
- Patient education regarding self-lymph node exam
- Avoidance of ultraviolet radiation exposure
Stage IB-IIA at Diagnosis
- Dermatologic evaluation every 3-6 months for the first 2 years the every 3-12 months for 3 years, then annually thereafter
- Patient education regarding monthly self-skin exams
- Patient education regarding self-lymph node exam
- Avoidance of ultraviolet radiation exposure
Stage IIB-IV at Diagnosis
- Imaging screening using either chest X-ray, CT scan, and/or positron emission tomography (PET) every 3-12 months AND brain MRI every year for the first 5 years.
- Dermatologic evaluation every 3-6 months for the first 2 years the every 3-12 months for 3 years, then annually thereafter
- Patient education regarding monthly self-skin exams
- Patient education regarding self-lymph node exam
- Avoidance of ultraviolet radiation exposure
References
- ↑ Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A; et al. (2013). "Melanoma, version 2.2013: featured updates to the NCCN guidelines". J Natl Compr Canc Netw. 11 (4): 395–407. PMID 23584343.